한글목차

실시간 PCR 및 디지털 PCR 동향과 예측

세계 실시간 PCR 및 디지털 PCR 시장 규모는 2024-2030년 연평균 7.2% 성장하여 2030년까지 약 128억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 감염성 질환의 유병률 증가, 바이오마커 탐색에서 PCR의 사용 확대, 분자 검사에 대한 선호도 증가 등입니다. 세계 실시간 PCR 및 디지털 PCR 시장의 미래는 병원 및 진단 센터, 실험실 및 학술 기관, 제약 및 생명공학, 임상 연구 기관, 법의학 연구소 시장에서의 기회로 인해 유망해 보입니다.

실시간 PCR 및 디지털 PCR 시장 인사이트

Lucintel의 예측에 따르면, 예측 기간 동안 임상 분야가 가장 높은 성장률을 보일 것으로 예상됩니다.

북미 지역은 만성질환의 높은 유병률, 새로운 첨단 유전체 분석 제품의 사용 증가, 주요 기업의 존재로 인해 가장 큰 지역으로 남을 것으로 보입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤나?

목차

제1장 주요 요약

제2장 세계의 실시간 PCR 및 디지털 PCR 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석 : 2018-2030년

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 실시간 PCR 및 디지털 PCR 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 실시간 PCR 및 디지털 PCR 시장 : 제품 유형별
  • 시약·소모품
  • 기기
  • 소프트웨어
• 세계의 실시간 PCR 및 디지털 PCR 시장 : 기술별
  • 정량적 PCR
  • 디지털 PCR
• 세계의 실시간 PCR 및 디지털 PCR 시장 : 용도별
  • 임상
  • 연구
  • 법의학
  • 기타
• 세계의 실시간 PCR 및 디지털 PCR 시장 : 최종 용도별
  • 병원·진단 센터
  • 연구실·학술기관
  • 제약·바이오 기술
  • 임상 조사기관
  • 법의학 연구소
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2018-2030년)

• 세계의 실시간 PCR 및 디지털 PCR 시장 : 지역별
• 북미의 실시간 PCR 및 디지털 PCR 시장
• 유럽의 실시간 PCR 및 디지털 PCR 시장
• 아시아태평양의 실시간 PCR 및 디지털 PCR 시장
• 기타 지역의 실시간 PCR 및 디지털 PCR 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품 유형별 세계 실시간 PCR 및 디지털 PCR 시장 성장 기회
  • 기술별 세계의 실시간 PCR 및 디지털 PCR 시장 성장 기회
  • 용도별 세계 실시간 PCR 및 디지털 PCR 시장 성장 기회
  • 최종 용도별 세계 실시간 PCR 및 디지털 PCR 시장 성장 기회
  • 지역별 세계의 실시간 PCR 및 디지털 PCR 시장 성장 기회
• 세계의 실시간 PCR 및 디지털 PCR 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 실시간 PCR 및 디지털 PCR 시장 생산능력 확대
  • 세계의 실시간 PCR 및 디지털 PCR 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• F. Hoffmann La Roche
• Takara Bio
• Becton and Dickinson
• Agilent Technologies
• Merck KGaA
• Qiagen
• Abbott Laboratories
• Thermo Fisher Scientific
• Danaher
• Bio Rad Laboratories

영문목차

Real-Time PCR and Digital PCR Trends and Forecast

The future of the global real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets. The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

A more than 150-page report is developed to help in your business decisions.

Real-Time PCR and Digital PCR by Segment

The study includes a forecast for the global real-time PCR and digital PCR by product type, technology, application, end use, and region.

Real-Time PCR and Digital PCR Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Reagents and Consumables
• Instruments
• Software

Real-Time PCR and Digital PCR Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Quantitative PCR
• Digital PCR

Real-Time PCR and Digital PCR Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Clinical
• Research
• Forensic
• Others

Real-Time PCR and Digital PCR Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Diagnostic Centers
• Research Laboratories and Academic Institutes
• Pharmaceutical and Biotechnology
• Clinical Research Organizations
• Forensic Laboratories
• Others

Real-Time PCR and Digital PCR Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Real-Time PCR and Digital PCR Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies real-time PCR and digital PCR companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the real-time PCR and digital PCR companies profiled in this report include-

• F. Hoffmann La Roche
• Takara Bio
• Becton and Dickinson
• Agilent Technologies
• Merck KGaA
• Qiagen
• Abbott Laboratories
• Thermo Fisher Scientific
• Danaher
• Bio Rad Laboratories

Real-Time PCR and Digital PCR Market Insights

Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Features of the Global Real-Time PCR and Digital PCR Market

Market Size Estimates: Real-time PCR and digital PCR market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Real-time PCR and digital PCR market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Real-time PCR and digital PCR market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the real-time PCR and digital PCR market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the real-time PCR and digital PCR market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the real-time PCR and digital PCR market size?

Answer: The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for real-time PCR and digital PCR market?

Answer: The global real-time PCR and digital PCR market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the real-time PCR and digital PCR market?

Answer: The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

Q4. What are the major segments for real-time PCR and digital PCR market?

Answer: The future of the real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets.

Q5. Who are the key real-time PCR and digital PCR market companies?

Answer: Some of the key real-time PCR and digital PCR companies are as follows:

• F. Hoffmann La Roche
• Takara Bio
• Becton and Dickinson
• Agilent Technologies
• Merck KGaA
• Qiagen
• Abbott Laboratories
• Thermo Fisher Scientific
• Danaher
• Bio Rad Laboratories

Q6. Which real-time PCR and digital PCR market segment will be the largest in future?

Answer: Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

Q7. In real-time PCR and digital PCR market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the real-time PCR and digital PCR market by product type (reagents and consumables, instruments, and software), technology (quantitative PCR and digital PCR), application (clinical, research, forensic, and others), end use (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology, clinical research organizations, forensic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Real-Time PCR and Digital PCR Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Real-Time PCR and Digital PCR Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Real-Time PCR and Digital PCR Market by Product Type
  • 3.3.1: Reagents and Consumables
  • 3.3.2: Instruments
  • 3.3.3: Software
• 3.4: Global Real-Time PCR and Digital PCR Market by Technology
  • 3.4.1: Quantitative PCR
  • 3.4.2: Digital PCR
• 3.5: Global Real-Time PCR and Digital PCR Market by Application
  • 3.5.1: Clinical
  • 3.5.2: Research
  • 3.5.3: Forensic
  • 3.5.4: Others
• 3.6: Global Real-Time PCR and Digital PCR Market by End Use
  • 3.6.1: Hospitals and Diagnostic Centers
  • 3.6.2: Research Laboratories and Academic Institutes
  • 3.6.3: Pharmaceutical and Biotechnology
  • 3.6.4: Clinical Research Organizations
  • 3.6.5: Forensic Laboratories
  • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Real-Time PCR and Digital PCR Market by Region
• 4.2: North American Real-Time PCR and Digital PCR Market
  • 4.2.1: North American Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
  • 4.2.2: North American Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
• 4.3: European Real-Time PCR and Digital PCR Market
  • 4.3.1: European Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
  • 4.3.2: European Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
• 4.4: APAC Real-Time PCR and Digital PCR Market
  • 4.4.1: APAC Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
  • 4.4.2: APAC Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
• 4.5: ROW Real-Time PCR and Digital PCR Market
  • 4.5.1: ROW Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
  • 4.5.2: ROW Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Technology
  • 6.1.3: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Application
  • 6.1.4: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by End Use
  • 6.1.5: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Region
• 6.2: Emerging Trends in the Global Real-Time PCR and Digital PCR Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Real-Time PCR and Digital PCR Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Real-Time PCR and Digital PCR Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann La Roche
• 7.2: Takara Bio
• 7.3: Becton and Dickinson
• 7.4: Agilent Technologies
• 7.5: Merck KGaA
• 7.6: Qiagen
• 7.7: Abbott Laboratories
• 7.8: Thermo Fisher Scientific
• 7.9: Danaher
• 7.10: Bio Rad Laboratories